Beta Bionics (NASDAQ:BBNX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Beta Bionics Announces Participation at Upcoming Investor Conferences
Beta Bionics, Inc. (NASDAQ:BBNX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$28.10 [Yahoo! Finance]
Beta Bionics (NASDAQ:BBNX) was given a new $32.00 price target on by analysts at Truist Financial Corporation.
Show more
Live Event:
Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team:
support@newsquantified.com